Current Medicinal Chemistry
Title:Meet Our Editorial Board Member:
Volume: 22 Issue: 16
Author(s): Isabel Haro
Affiliation:
Export Options
About this article
Cite this article as:
Haro Isabel, Meet Our Editorial Board Member:, Current Medicinal Chemistry 2015; 22 (16) . https://dx.doi.org/10.2174/092986732216150514124527
DOI https://dx.doi.org/10.2174/092986732216150514124527 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis
Current Drug Research Reviews Patent Selections
Recent Patents on Medical Imaging Dual Role of S100A8 and S100A9 in Inflammation-Associated Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Insights on the Neuromodulatory Propensity of Selaginella (Sanjeevani) and its Potential Pharmacological Applications
CNS & Neurological Disorders - Drug Targets Cytokines in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Design Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews The Inflammatory Milieu of the Degenerate Disc: Is Mesenchymal Stem Cell-based Therapy for Intervertebral Disc Repair a Feasible Approach?
Current Stem Cell Research & Therapy Improving of Nutraceutical Features of Many Important Mediterranean Vegetables by Inoculation with a New Commercial Product
Current Pharmaceutical Biotechnology Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Brittle Asthma
Current Respiratory Medicine Reviews Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
Current Medicinal Chemistry Patients Presenting with a Hot, Swollen Joint: A Single-Centre Retrospective Analysis
Current Rheumatology Reviews Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Arthropathy in Patients with CREST Variant Scleroderma
Current Rheumatology Reviews Fragment Based Drug Design: From Experimental to Computational Approaches
Current Medicinal Chemistry Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment
Current Drug Targets Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Benzo[a]pyrene Toxicity and Inflammatory Disease
Current Rheumatology Reviews Flavonoids as Multi-Target Compounds in Drug Discovery
Mini-Reviews in Organic Chemistry